Taken together, ZNF224 in CML acts as a tumor suppressor that is able to promote the expression of proapoptotic genes and repress the expression of antiapoptotic genes to enhance drug resistance. Here, ZNF224 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.